The adjustment in price target by Morgan Stanley is minor, suggesting a neutral outlook without significant change in the company's valuation or prospects. The Equal-Weight rating indicates that the analyst does not see Oracle as underperforming or outperforming the broader market or sector in the short term. Therefore, the impact on the stock price is likely to be limited unless accompanied by more substantial news or changes in the company's performance.